{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:49:22Z","timestamp":1779346162710,"version":"3.51.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world. Although the treatment landscape for CLL is rapidly evolving, there are still some patients who develop drug resistance or disease refractory.  Ferroptosis is a type of lipid peroxidation\u2013induced cell death and has been suggested to have prognostic value in several cancers. Our research aims to build a prognostic model to improve risk stratification in CLL patients and facilitate more accurate assessment for clinical management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The differentially expressed ferroptosis-related genes (FRGs) in CLL were filtered through univariate Cox regression analysis based on public databases. Least absolute shrinkage and selection operator (LASSO) Cox algorithms were performed to construct a prognostic risk model.\u00a0CIBERSORT and single-sample gene set enrichment analysis (ssGSEA) were performed to estimate the immune infiltration score and immune-related pathways. A total of 36 CLL patients in our center were enrolled in this study as a validation cohort. Moreover, a nomogram model was established to predict the prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 15 differentially expressed FRGs with prognostic significance were screened out. After minimizing the potential risk of overfitting, we constructed a novel ferroptosis-related prognostic score (FPS) model with nine FRGs (AKR1C3, BECN1, CAV1, CDKN2A, CXCL2, JDP2, SIRT1, SLC1A5, and SP1) and stratified patients into low- and high-risk groups. Kaplan\u2013Meier analysis showed that patients with high FPS had worse overall survival (OS) (<jats:italic>P<\/jats:italic>&amp;lt;0.0001) and treatment-free survival (TFS) (<jats:italic>P<\/jats:italic>&amp;lt;0.0001). ROC curves evaluated the prognostic prediction ability of the FPS model. Additionally, the immune cell types and immune-related pathways were correlated with the risk scores in CLL patients. In the validation cohort, the results confirmed that the high-risk group was related to worse OS (<jats:italic>P<\/jats:italic>&amp;lt;0.0001), progress-free survival (PFS) (<jats:italic>P<\/jats:italic>=0.0140), and TFS (<jats:italic>P<\/jats:italic>=0.0072). In the multivariate analysis, only FPS (<jats:italic>P<\/jats:italic>=0.011) and CLL-IPI (<jats:italic>P<\/jats:italic>=0.010) were independent risk indicators for OS. Furthermore, we established a nomogram including FPS and CLL-IPI that could strongly and reliably predict individual prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A novel FPS model can be used in CLL for prognostic prediction. The model index may also facilitate the development of new clinical ferroptosis-targeted therapies in patients with CLL.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.962000","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T04:43:20Z","timestamp":1665031400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia"],"prefix":"10.3389","volume":"13","author":[{"given":"Bihui","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangdi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic lymphocytic leukemia","volume":"333","author":"Rozman","year":"1995","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am J Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0366-8","article-title":"New roles for b cell receptor associated kinases: when the b cell is not the target","volume":"33","author":"Nguyen","year":"2019","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.138","article-title":"Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies","volume":"2013","author":"Hallek","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.02.021","article-title":"Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia b-cells","volume":"7","author":"Efremov","year":"2007","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-338855","article-title":"Packham G","volume":"118","author":"Stevenson","year":"2011","journal-title":"B-cell receptor Signaling chronic lymphocytic Leuk Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/asheducation.V2012.1.88.3801172","article-title":"Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia","volume":"2012","author":"Wiestner","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.789517","article-title":"Recent progress of ferroptosis in lung diseases","volume":"9","author":"Yu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.739392","article-title":"Ferroptosis-mediated crosstalk in the tumor microenvironment implicated in cancer progression and therapy","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3658196","DOI":"10.1155\/2021\/3658196","article-title":"Ferroptosis-associated classifier and indicator for prognostic prediction in cutaneous melanoma","volume":"2021","author":"Zeng","year":"2021","journal-title":"J Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S309846","article-title":"Ferroptosis-related gene signature: A new method for personalized risk assessment in patients with diffuse Large b-cell lymphoma","volume":"14","author":"Chen","year":"2021","journal-title":"Pharmacogenomics Person Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.778492","article-title":"The role of iron in cancer progression","volume":"11","author":"Guo","year":"2021","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v13.i11.1668","article-title":"Novel perspective in pancreatic cancer therapy: Targeting ferroptosis pathway","volume":"13","author":"Yang","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111785","article-title":"Nanoparticles for ferroptosis therapy in cancer","volume":"13","author":"Zaffaroni","year":"2021","journal-title":"Pharmaceutics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaa021","article-title":"FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations","volume":"2020","author":"Zhou","year":"2020","journal-title":"Database J Biol Database Curation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The lasso method for variable selection in the cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1182\/blood-2014-02-556399","article-title":"Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia","volume":"124","author":"Pflug","year":"2014","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25166","article-title":"Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells","volume":"9","author":"Vangapandu","year":"2018","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","first-page":"106013","DOI":"10.1016\/j.phrs.2021.106013.","article-title":"p53: A double-edged sword in tumor ferroptosis","volume":"117","author":"Ji","year":"2021","journal-title":"Pharmacol Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184681","article-title":"Targeting the p53 pathway in CLL: State of the art and future perspectives","volume":"13","author":"Kwok","year":"2021","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00090","article-title":"Potent and highly selective aldo-keto reductase 1C3 (AKR1C3) inhibitors act as chemotherapeutic potentiators in acute myeloid leukemia and T-cell acute lymphoblastic leukemia","volume":"62","author":"Verma","year":"2019","journal-title":"J Med Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S329031","article-title":"Evaluation of ferroptosis-related gene AKR1C1 as a novel biomarker associated with the immune microenvironment and prognosis in breast cancer","volume":"14","author":"Zhang","year":"2021","journal-title":"Int J Gen Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.672735","article-title":"CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells M in vitro","volume":"53","author":"Burgess","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"B27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","article-title":"Ferroptosis is a type of autophagy-dependent cell death","volume":"66","author":"Zhou","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.821676","article-title":"Genetic and epigenetic signatures in acute promyelocytic leukemia treatment and molecular remission","volume":"13","author":"Borutinskait\u0117","year":"2022","journal-title":"Front Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.711776","article-title":"An original ferroptosis-related gene signature effectively predicts the prognosis and clinical status for colorectal cancer patients","volume":"11","author":"Shao","year":"2021","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4706","article-title":"Identification and validation of a ferroptosis-29 related gene signature for predicting survival in skin cutaneous melanoma","author":"Ping","year":"2022","journal-title":"Cancer Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell Signal"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.05.011","article-title":"SIRT1-autophagy axis inhibits excess iron-induced ferroptosis of foam cells and subsequently increases IL-1\u03b2 and IL-18","volume":"561","author":"Su","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013201","article-title":"The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation","volume":"139","author":"Amaya","year":"2022","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7007933","DOI":"10.1155\/2021\/7007933","article-title":"Comprehensive analysis of ferroptosis-related markers for the clinical and biological value in gastric cancer","volume":"2021","author":"Shao","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41420-021-00610-0","article-title":"Effect of endothelial progenitor cell-derived extracellular vesicles on endothelial cell ferroptosis and atherosclerotic vascular endothelial injury","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Discov"},{"key":"B36","doi-asserted-by":"publisher","first-page":"43228","DOI":"10.1038\/srep43228","article-title":"Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase C\u03b2II in chronic lymphocytic leukaemia cells","volume":"7","author":"Al-Sanabra","year":"2017","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.leukres.2018.01.006","article-title":"Targeting the IL-17\/IL-6 axis can alter growth of chronic lymphocytic leukemia in vivo\/in vitro","volume":"66","author":"Zhu","year":"2018","journal-title":"Leuk Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12964-020-00663-1","article-title":"The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma","volume":"18","author":"Tang","year":"2020","journal-title":"Cell Commun Signaling CCS"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2016.07.005","article-title":"NF-\u03baB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions","volume":"39","author":"Mansouri","year":"2016","journal-title":"Semin Cancer Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/biology9090285","article-title":"A glance of p53 functions in brain development, neural stem cells, and brain cancer","volume":"9","author":"Xiong","year":"2020","journal-title":"Biology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2021.6274","article-title":"A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia","volume":"22","author":"Huang","year":"2021","journal-title":"Bosnian J Basic Med Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.739011","article-title":"Prognostic value of a ferroptosis-related gene signature in patients with head and neck squamous cell carcinoma","volume":"9","author":"He","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.45050","article-title":"A novel ferroptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma","volume":"16","author":"Liang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.962000\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T04:43:26Z","timestamp":1665031406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.962000\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2022.962000"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.962000","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"962000"}}